Abstract:Background Peripheral arterial disease (PAD) is highly prevalent and particularly in elders, smokers, diabetics or patients with systemic atherosclerosis. Apart from the surgery and medication, stem cell transplantation offers promising approaches for therapeutic angiogenesis and tissue repair. In this study we try to use in vivo multimodality molecular imaging strategies to investigate adipose tissue-derived mesenchymal stem cells (MSCs) survival, function and relative mechanism. Method MSCs were cultured from murine adipose tissue from transgenic mice, which carried double reporter genes: firefly luciferase (Fluc) and enhanced green fluorescent protein (eGFP), by collagenase digestion method. Hindlimb ischaemia animal model was created in male nude mice by ligating the proximal and distal femoral artery. MSCs (1×105) along with/without VEGF (0.4 ng) were transplanted into ischaemic hindlimb. The animals were subjected to be imaged by bioluminescence imaging and CT scan. Laser Doppler perfusion imaging (LDPI) were used to show the spatiotemporal images of peripheral tissue blood perfusion. Micro-CT, histological and molecular analysis were tested to confirm the cells9 location and angiogenesis anatomically and mechanically. Result The colour-coded index of LDPI was significantly higher in the MSCs-transplanted group than that in the control group from day 3 to 28 post cell transplantation. On day 3 after transplantation, the bioluminescence signals in MSCs with VEGF group were 4.6×106±2.5×105 photons/s/cm2/sr, while in MSCs group were 2.8×106±3.1×105 photons/s/cm2/sr, respectively (p<0.01 vs control). The signals of bioluminescence increased gradually from POD 3 to day 21, which proved survival and proliferation of the MSCs in the host. The group treated with MSCs and VEGF showed higher signals than that injected by MSCs only, which indicated the reinforcement of VEGF. Micro-CT angiography demonstrated more angiogenesis in the hindlimbs of the treated mice on day 21, which were also confirmed by molecular analysis. Histological analysis showed that MSCs therapy recovered vessel density compared with the control group. Conclusion Bioluminescence fusion with CT scan provides higher detailed 3D imaging for monitoring MSCs in vivo. Angiogenesis activator VEGF might promote MSCs9 beneficial function for hindlimb ischaemia therapy.

Adipose Derived Stromal Vascular Fraction and Mesenchymal Stem Cells Improve Angiogenesis in a Rat Hindlimb Ischaemia Model

Therapeutic Angiogenesis of Bone Marrow Mononuclear Cells (mncs) and Peripheral Blood Mncs: Transplantation for Ischemic Hindlimb

Intramuscular administration of vascular endothelial growth factor augmenting collateral circulation in a rat hindlimb replantation model.

Intramuscular Administration of Vascular Endothelial Growth Factor Augmenting Collateral Circulation in a Rat Hindlimb Replantation Model

Adipose-derived stem cells improve neovascularization in ischemic flaps in diabetic mellitus through HIF-1α/VEGF pathway.

Adipose Stromal Cells Amplify Angiogenic Signaling Via The Vegf/Mtor/Akt Pathway In A Murine Hindlimb Ischemia Model: A 3d Multimodality Imaging Study

Angiogenic effects of cell therapy within a biomaterial scaffold in a rat hind limb ischemia model

Exosomes from adipose-derived stem cells promote angiogenesis and reduce necrotic grade in hindlimb ischemia mouse models

Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice

Regenerative Effect of Umbilical Cord-Derived Mesenchymal Stromal Cells in a Rat Model of Established Limb Ischemia

Therapeutic Effect of Adipose Derived Mesenchymal Stem Cell Transplantation in Reducing Restenosis in a Murine Angioplasty Model

Adipose-Derived Stromal Cells Amplify the Angiogenic Signal Via Vegf/Mtor/Akt Pathway in the Murine Peripheral Arterial Disease Model: an in Vivo 3d Multimodality Imaging Study

Vascular Endothelial Grow Factor 165 and Angiopoitin-1 Augment Revascularization in a Rat Hindlimb Ischemia Model

E0009 Multimodality Molecular Imaging of Adipose-Derived Mesenchymal Stem Cells with VEGF in Hindlimb Ischaemia Mice

Genetically Modified Human Placenta-Derived Mesenchymal Stem Cells with Fgf-2 and Pdgf-Bb Enhance Neovascularization in A Model of Hindlimb Ischemia

Extracorporeal shock wave-assisted adipose-derived fresh stromal vascular fraction restores the blood flow of critical limb ischemia in rat

A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats.

Astragaloside IV promotes the angiogenic capacity of adipose-derived mesenchymal stem cells in a hindlimb ischemia model by FAK phosphorylation via CXCR2

Subpial transplantation of adipose-derived stem cells alleviates paraplegia in a rat model of aortic occlusion/reperfusion-induced spinal cord infarction

Human-Induced Pluripotent Stem-Cell-Derived Smooth Muscle Cells Increase Angiogenesis to Treat Hindlimb Ischemia

Transplantation Of Mesenchymal Stem Cells Enhances Angiogenesis After Ischemic Limb Injury In Mice